Modification of myocardial substrate use as a therapy for heart failure
- 1 September 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Cardiovascular Medicine
- Vol. 3 (9), 490-498
- https://doi.org/10.1038/ncpcardio0583
Abstract
Despite advances in treatment, chronic heart failure is still associated with significant morbidity and a poor prognosis. The scope for further advances based on additional neurohumoral blockade is small. Effective adjunctive therapies acting via a different cellular mechanism would, therefore, be attractive. Energetic impairment seems to contribute to the pathogenesis of heart failure. The findings from several studies have shown that the so-called metabolic agents could have potential as adjunctive therapies in heart failure. These agents cause a shift in the substrate used by the heart away from free fatty acids, the oxidation of which normally provides around 70% of the energy needed, towards glucose. The oxygen cost of energy generation is lessened when glucose is used as the substrate. In this review we aim to draw attention to the metabolic alteration in heart failure and we present evidence supporting the use of metabolic therapy in heart failure.Keywords
This publication has 67 references indexed in Scilit:
- ATP flux through creatine kinase in the normal, stressed, and failing human heartProceedings of the National Academy of Sciences, 2005
- Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathyJournal of the American College of Cardiology, 2003
- Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopyJournal of the American College of Cardiology, 2002
- Progressive Loss of Myocardial ATP Due to a Loss of Total Purines During the Development of Heart Failure in DogsCirculation, 1999
- Subcellular Creatine Kinase AlterationsCirculation Research, 1999
- The Molecular Energetics of the Failing Heart from Animal Models―Small Animal ModelsHeart Failure Reviews, 1999
- The Molecular Energetics of the Failing Heart from Animal Models—Large Animal ModelsHeart Failure Reviews, 1999
- Human myocardial ATP content and in vivo contractile functionMolecular and Cellular Biochemistry, 1998
- Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopyThe Lancet, 1991
- Human myocardial adenosine triphosphatase activities in health and heart failureAmerican Heart Journal, 1988